Medication info
Telmisartan Plus Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Telmisartan Plus Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Halim Pharmaceutical Co., Ltd.
Appearance
White or nearly white, bilaterally convex round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900127 · Approved 2019.01.11 · Insurance code 645305980

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.
Child dose
Children under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Halim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential Hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Telmisartan. It effectively lowers blood pressure and helps reduce the risk of complications caused by hypertension. Therefore, this medication plays an important role in the treatment of hypertension and assists in blood pressure management.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.

Child dose

Children under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with allergies to any of the ingredients contained in this medication or those with certain liver or kidney diseases should not take it. Elderly patients, patients with abnormal potassium levels in the blood, and those with impaired liver function should use this medication with caution. While taking this medication, caution is needed as side effects such as dizziness, hypotension, and electrolyte imbalances may occur. Particularly, the risk of skin cancer may increase, so it is necessary to avoid sun exposure and regularly check the condition of the skin. This medication may interact with other antihypertensive drugs or specific medications, so it is essential to consult a doctor. Women who are pregnant or breastfeeding should not take this medication, and those planning to become pregnant should also consult a doctor beforehand. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, and immediate contact with a medical institution is required. This medication is not recommended for children under 18, as its safety and efficacy have not been established. During treatment, one should be cautious while driving or operating hazardous machinery as dizziness or drowsiness may occur.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it should be kept at room temperature between 1°C and 30°C. Storing it this way can help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

White or nearly white, bilaterally convex round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.